Legislative solutions can incentivize research and development for lifesaving antimicrobials.
Emily Wheeler
Advertisement
Emily Wheeler is vice president of infectious disease policy at the Biotechnology Innovation Organization and director of Working to Fight AMR.
Articles by Emily Wheeler
Advertisement
Latest Updated Articles
Doctors — and patients — need new antibiotics. But a broken market can't deliver them.Published: August 25th 2025 | Updated:
Advertisement
Advertisement
Trending on Medical Economics
1
What medical practices need to know about the private equity resurgence
2
Improved physician leadership: A key to better health care
3
FDA clears neonatal MRI system designed for NICU use
4
Health care bankruptcies drop in 2025, but that doesn’t mean all is well for 2026
5